Thu, 21 March 2013
Dr. Greg Riely on the Most Promising Upcoming New Targeted Agents and Molecular Pathways for Lung Cancer Treatment
Dr. Greg Riely, Memorial Sloan-Kettering, provides his view on the targeted therapy approaches most likely to become clinically useful in lung cancer over the next several years.
Direct download: GRACEcastUC-060_Lung-Video_Riely_Most_Promising_Targeted_Rx_for_LC.m4v
Category:Lung-Cancer-Video -- posted at: 4:28pm PDT